CytoMed Therapeutics Statistics

Total Valuation

GDTC has a market cap or net worth of $26.31 million. The enterprise value is $23.01 million.

Market Cap	26.31M
Enterprise Value	23.01M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

GDTC has 11.54 million shares outstanding. The number of shares has increased by 8.56% in one year.

Current Share Class	11.54M
Shares Outstanding	11.54M
Shares Change (YoY)	+8.56%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	18.79%
Owned by Institutions (%)	0.13%
Float	3.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	71.33
Forward PS	49.61
PB Ratio	4.00
P/TBV Ratio	4.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	62.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.89, with a Debt / Equity ratio of 0.05.

Current Ratio	9.89
Quick Ratio	8.39
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-154.11

Financial Efficiency

Return on equity (ROE) is -24.86% and return on invested capital (ROIC) is -18.46%.

Return on Equity (ROE)	-24.86%
Return on Assets (ROA)	-17.44%
Return on Invested Capital (ROIC)	-18.46%
Return on Capital Employed (ROCE)	-33.09%
Revenue Per Employee	$8,578
Profits Per Employee	-$42,885
Employee Count	43
Asset Turnover	0.04
Inventory Turnover	0.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.34% in the last 52 weeks. The beta is -0.29, so GDTC's price volatility has been lower than the market average.

Beta (5Y)	-0.29
52-Week Price Change	+6.34%
50-Day Moving Average	2.45
200-Day Moving Average	2.28
Relative Strength Index (RSI)	46.04
Average Volume (20 Days)	11,792

Short Selling Information

The latest short interest is 76,960, so 0.67% of the outstanding shares have been sold short.

Short Interest	76,960
Short Previous Month	87,660
Short % of Shares Out	0.67%
Short % of Float	2.26%
Short Ratio (days to cover)	2.78

Income Statement

In the last 12 months, GDTC had revenue of $368,838 and -$1.84 million in losses. Loss per share was -$0.16.

Revenue	368,838
Gross Profit	346,089
Operating Income	-2.29M
Pretax Income	-3.12M
Net Income	-1.84M
EBITDA	-2.05M
EBIT	-2.29M
Loss Per Share	-$0.16

Full Income Statement

Balance Sheet

The company has $3.64 million in cash and $339,439 in debt, giving a net cash position of $3.30 million or $0.29 per share.

Cash & Cash Equivalents	3.64M
Total Debt	339,439
Net Cash	3.30M
Net Cash Per Share	$0.29
Equity (Book Value)	6.63M
Book Value Per Share	0.57
Working Capital	3.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.99 million and capital expenditures -$1.03 million, giving a free cash flow of -$3.15 million.

Operating Cash Flow	-1.99M
Capital Expenditures	-1.03M
Free Cash Flow	-3.15M
FCF Per Share	-$0.27

Full Cash Flow Statement

Margins

Gross Margin	93.83%
Operating Margin	-621.91%
Pretax Margin	-500.99%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GDTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.56%
Shareholder Yield	-8.56%
Earnings Yield	-7.01%
FCF Yield	-11.97%

Analyst Forecast

The average price target for GDTC is $5.00, which is 120.75% higher than the current price. The consensus rating is "Buy".

Price Target	$5.00
Price Target Difference	120.75%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GDTC has an Altman Z-Score of 18.34 and a Piotroski F-Score of 1.

Altman Z-Score	18.34
Piotroski F-Score	1